Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
Yieldshares High Income ETF | YYY | Nov 25, 2024 | 12.22 | +0.58 |
Yiren Digital ADR | YRD | Nov 25, 2024 | 4.67 | -3.71 |
York Water | YORW | Nov 25, 2024 | 36.07 | -0.30 |
Yoshiharu Global A | YOSH | Nov 25, 2024 | 3.30 | -8.71 |
Yotta Acquisition | YOTA | Nov 25, 2024 | 11.24 | 0.00 |
Yotta Acquisition Unit | YOTAU | Nov 25, 2024 | 11.19 | 0.00 |
Youdao A ADR | DAO | Nov 25, 2024 | 5.30 | +2.32 |
YPF Sociedad Anonima ADR | YPF | Nov 25, 2024 | 39.26 | -1.92 |
Yum China | YUMC | Nov 25, 2024 | 47.58 | +1.08 |
Yum! Brands | YUM | Nov 25, 2024 | 137.05 | +1.32 |
Yunhong Green CTI | YHGJ | Nov 25, 2024 | 0.68 | -0.13 |
Yunji ADR | YJ | Nov 25, 2024 | 1.75 | +3.24 |
YXT.COM Group Holding | YXT | Nov 25, 2024 | 2.99 | +45.85 |
YY Group Holding | YYGH | Nov 25, 2024 | 1.85 | -6.33 |
Zai Lab ADR | ZLAB | Nov 25, 2024 | 28.09 | +6.28 |
Zapp Electric Vehicles Group | ZAPP | Nov 25, 2024 | 1.75 | -6.91 |
ZC SP ETN REDEEM 19/07/2050 USD 25 - Ser B | AMND | Nov 25, 2024 | 54.67 | -1.66 |
ZC SP ETN REDEEM 20/10/2050 USD 25 - Series B | AMTR | Nov 25, 2024 | 79.19 | -2.03 |
Zebra Technologies A | ZBRA | Nov 25, 2024 | 400.94 | +0.94 |
Zedge B | ZDGE | Nov 25, 2024 | 2.64 | +2.33 |
ZEEKR Intelligent Technology Holding | ZK | Nov 25, 2024 | 23.36 | +4.29 |
ZenaTech | ZENA | Nov 25, 2024 | 6.42 | 0.00 |
Zentalis Pharmaceuticals | ZNTL | Nov 25, 2024 | 3.50 | +8.36 |
Zentek | ZTEK | Nov 25, 2024 | 1.15 | 0.00 |
Zenvia A | ZENV | Nov 25, 2024 | 1.53 | +9.29 |
Zeo Energy A | ZEO | Nov 25, 2024 | 1.34 | +2.29 |
Zepp Health ADR | ZEPP | Nov 25, 2024 | 2.84 | +14.52 |
Zeta Global A | ZETA | Nov 25, 2024 | 21.27 | -4.96 |
Zevia A | ZVIA | Nov 25, 2024 | 2.32 | +5.94 |
Zevra Therapeutics | ZVRA | Nov 25, 2024 | 9.49 | -0.99 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.